Healthpeak Properties, Inc.

🇺🇸New York Stock Exchange
Back to all articles
Healthpeak Properties, Inc. stock analysis DOC overview
Bullish +65

Healthpeak Properties (NYSE:DOC) Hits New 1-Year High - Time to Buy?

📈 DOC stock hit a new 52-week high of $21.91 during Tuesday trading with volume exceeding 6 million shares.

💰 Q1 earnings beat estimates with $0.45 EPS versus the consensus of $0.43 and revenue of $752.95 million.

📈 Revenue grew 7.1% year-over-year, demonstrating solid top-line performance in the healthcare real estate sector.

🎯 FY 2026 guidance set between $1.710-$1.750 EPS aligns with analyst consensus forecasts of $1.75.

🏦 Major institutions including State Street, JPMorgan, and Fuller & Thaler increased their holdings in Q4.

💸 Company paid a monthly dividend of $0.1017 per share on June 26th with a yield of 5.6%.

📊 Analyst sentiment improved recently with multiple firms raising price targets to the $21.00 level.

🏢 Business model focuses on life science facilities, medical office buildings, and senior housing communities.

📉 Insider Scott R. Bohn sold 10,989 shares in May for a total of $213,736, reducing his stake by 59%.

🏛️ Corporate insiders collectively own only 0.23% of the company's outstanding stock.

Bullish Signals
  • Stock price reached a new 52-week high of $21.91, indicating strong market momentum and investor confidence.
  • Quarterly EPS of $0.45 beat analyst consensus estimates by $0.02, signaling operational strength.
  • Revenue of $752.95 million exceeded expectations of $694.59 million, showing robust demand for healthcare assets.
  • Year-over-year revenue growth of 7.1% demonstrates sustainable business expansion in the sector.
  • Multiple major banks including JPMorgan and Royal Bank of Canada raised price targets to $21.00.
  • Significant institutional buying activity with State Street, JPMorgan, and Fuller & Thaler increasing stakes.
  • Strong dividend yield of 5.6% provides attractive income for shareholders despite high payout ratio.
  • Analyst consensus remains stable with an average price target of $19.93 supporting current valuation.
Risk Factors
  • Insider Scott R. Bohn sold a significant portion of his holdings, reducing his position by 59% in May.
  • High dividend payout ratio of 381.25% suggests the company is paying out more than its current earnings generate.
Full Analysis
Healthpeak Properties (NYSE:DOC) shares reached a new 52-week high of $21.91 on Tuesday, trading near $21.895 with significant volume. The stock has seen multiple analyst upgrades and price target increases recently, including JPMorgan raising its target to $21.00 and Royal Bank of Canada boosting its objective to $21.00, reflecting growing institutional interest in the healthcare real estate sector. The company reported strong quarterly earnings on May 5th, delivering $0.45 EPS which beat consensus estimates of $0.43. Revenue reached $752.95 million, surpassing analyst expectations of $694.59 million and growing 7.1% year-over-year. Healthpeak also provided FY 2026 guidance ranging between $1.710 and $1.750 EPS, aligning closely with the average analyst forecast of $1.75. Institutional ownership remains robust at 93.57%, with major firms like State Street, JPMorgan, and Fuller & Thaler increasing their stakes in the fourth quarter. The company recently paid a dividend of $0.1017 per share on June 26th, offering a yield of 5.6% to shareholders of record as of June 15th, though the payout ratio stands at 381.25%. Healthpeak Properties operates as a REIT focused on healthcare real estate assets, including life science research facilities, medical office buildings, and senior housing communities. While insider Scott R. Bohn sold shares in May, reducing his position by 59%, the overall market sentiment remains positive driven by earnings beats, revenue growth, and sustained institutional accumulation.